Publications

RECENT SELECTED PUBLICATIONS 

2021

Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.

Weingarten-Gabbay S, Klaeger S, Sarkizova S, Pearlman LR, Chen DY, Gallagher KME, Bauer MR, Taylor HB, Dunn WA, Tarr C, Sidney J, Rachimi S, Conway HL, Katsis K, Wang Y, Leistritz-Edwards D, Durkin MR, Tomkins-Tinch CH, Finkel Y, Nachshon A, Gentili M, Rivera KD, Carulli IP, Chea VA, Chandrashekar A, Bozkus CC, Carrington M; MGH COVID-19 Collection & Processing Team, Bhardwaj N, Barouch DH, Sette A, Maus MV, Rice CM, Clauser KR, Keskin DB, Pregibon DC, Hacohen N, Carr SA, Abelin JG, Saeed M, Sabeti PC. Cell. 2021.

 

MMP2 and TLRs modulate immune responses in the tumor microenvironment.

Muniz-Bongers LR, McClain CB, Saxena M, Bongers G, Merad M, Bhardwaj N. JCI Insight. 2021.

 

Myeloid Cell-associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing.

Wang L, Sfakianos JP, Beaumont KG, Akturk G, Horowitz A, Sebra RP, Farkas AM, Gnjatic S, Hake A, Izadmehr S, Wiklund P, Oh WK, Szabo PM, Wind-Rotolo M, Unsal-Kacmaz K, Yao X, Schadt E, Sharma P, Bhardwaj N, Zhu J, Galsky MD. Clin Cancer Res. 2021.

 

Uncloaking Breast Tumor Neoantigens with Radiation.

Newman JH, Bhardwaj N. Trends Immunol. 2021.

 

Super(antigen) target for SARS-CoV-2.

Brown M, Bhardwaj N. Nat Rev Immunol. 2021

 

2020

Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors.

Roudko V, Bozkus CC, Orfanelli T, McClain CB, Carr C, O’Donnell T, Chakraborty L, Samstein R, Huang KL, Blank SV, Greenbaum B, Bhardwaj N. Cell. 2020.

 

Unexplored horizons of cDC1 in immunity and tolerance.

Balan S, Radford KJ, Bhardwaj N. Adv Immunol. 2020.

 

TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancer.

Attalla K, Farkas AM, Anastos H, Audenet F, Galsky MD, Bhardwaj N, Sfakianos JP. Urol Oncol. 2020.

 

Cross-Presentation of Tumor Antigens Is Ruled by Synaptic Transfer of Vesicles among Dendritic Cell Subsets.

Balan S, Bhardwaj N. Cancer Cell. 2020.

 

A conserved dendritic-cell regulatory program limits antitumour immunity.

Maier B, Leader AM, Chen ST, Tung N, Chang C, LeBerichel J, Chudnovskiy A, Maskey S, Walker L, Finnigan JP, Kirkling ME, Reizis B, Ghosh S, D’Amore NR, Bhardwaj N, Rothlin CV, Wolf A, Flores R, Marron T, Rahman AH, Kenigsberg E, Brown BD, Merad M. Nature 2020.

 

 

Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma.

Perumal D, Imai N, Laganà A, Finnigan J, Melnekoff D, Leshchenko VV, Solovyov A, Madduri D, Chari A, Cho HJ, Dudley JT, Brody JD, Jagannath S, Greenbaum B, Gnjatic S, Bhardwaj N, Parekh S. Clin Cancer Res. 2020.

 

Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma.

Pavlick A, Blazquez AB, Meseck M, Lattanzi M, Ott PA, Marron TU, Holman RM, Mandeli J, Salazar AM, McClain CB, Gimenez G, Balan S, Gnjatic S, Sabado RL, Bhardwaj N. Cancer Immunol Res. 2020.

 

————————————————————————————

FOR A LIST OF ALL PUBLICATIONS – CLICK HERE

————————————————————————————